PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Spherics
Spherics focused on applying its oral drug delivery platform to develop products with improved therapeutic profiles.
Spherics
Mansfield, MA
